U2Bio Co (XKRX:221800) EV-to-EBIT : 205.27 (As of May. 26, 2024)

U2Bio Co EV-to-EBIT Chart

U2Bio Co Annual Data
	Trend	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23
EV-to-EBIT		Get a 7-Day Free Trial				33.98	61.51	6.53	1.80	312.29

Competitive Comparison of U2Bio Co's EV-to-EBIT

For the Diagnostics & Research subindustry, U2Bio Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

U2Bio Co's EV-to-EBIT Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, U2Bio Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where U2Bio Co's EV-to-EBIT falls into.

U2Bio Co EV-to-EBIT Calculation

U2Bio Co's EV-to-EBIT for today is calculated as:

U2Bio Co's current Enterprise Value is ₩15,287 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. U2Bio Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was ₩74 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

U2Bio Co  (XKRX:221800) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

U2Bio Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

U2Bio Co's Enterprise Value for the quarter that ended in Dec. 2023 was ₩23,257 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. U2Bio Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was ₩74 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

U2Bio Co EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of U2Bio Co's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

U2Bio Co (XKRX:221800) Business Description